Newsroom
Sorted by: Latest
-
Balyasny Asset Management LP UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Balyasny Asset Management L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be...
-
Vitamix® Debuts Vitamix Nano™, Bringing Iconic Performance to the Single‑Serve Category
CLEVELAND--(BUSINESS WIRE)--Vitamix®, the brand trusted for premium blending performance for more than 100 years, today announced the launch of Vitamix Nano™, a corded personal blender that delivers the power and durability Vitamix is known for in a compact, single‑serve format. Designed for health‑focused consumers navigating busy, independent routines, Nano makes it easy to create perfectly smooth personal‑size smoothies and frozen drinks with a streamlined single‑dial interface and a smaller...
-
Alnylam to Present New Data Reinforcing Strength in RNAi-Powered TTR Silencing and Continued Progress in Hypertension at ESC Congress 2026
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced that it will present new clinical and real-world data across its transthyretin-mediated amyloidosis (ATTR) and hypertension programs at the European Society of Cardiology (ESC) Congress 2026, taking place August 28-31, 2026, in Munich, Germany. These presentations add to the existing and growing body of evidence demonstrating strength in RNAi-powered transthyre...
-
Corpay to Participate in Upcoming Investor Conferences
ATLANTA--(BUSINESS WIRE)--Corpay, Inc., (NYSE: CPAY), the corporate payments company, today announced that the Company will participate in the following investor conferences: On Thursday, August 27, 2026, the Company will be attending the 2026 Deutsche Bank Technology Conference in Dana Point, CA. Management will participate in a fireside chat beginning at 3:20 pm PT. On Tuesday, September 15, 2026, the Company will be attending the Oppenheimer Fintech Leaders Conference in New York, NY. On Tue...
-
Global Payments Announces Genius World, an Immersive Event Showcasing the Future of Commerce
ATLANTA--(BUSINESS WIRE)--Global Payments Inc. (NYSE: GPN) today announced Genius World, the company’s inaugural flagship event showcasing the full line of Genius™ solutions....
-
GeneDx Announces Transformative Study Supporting Hospital-Wide Adoption of Rapid Genomic Sequencing at Seattle Children’s
GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx and Seattle Children’s show hospital-wide rapid genome sequencing accelerates accurate diagnosis and expands access to answers for children....
-
Audrey Mascarenhas Sets the Record Straight for Fellow Questor Shareholders
CALGARY, Alberta--(BUSINESS WIRE)--Dear Fellow Shareholders, I am writing to correct the record and explain why this upcoming meeting is about restoring disciplined governance, credible strategy, and shareholder-aligned leadership at Questor Technology Inc. (“Questor” or the “Company”). For more than 26 years, I helped build Questor’s technology, commercial relationships and market position, and as the Company’s largest shareholder, with approximately 18.62% ownership, direction or control (bas...
-
Tempus Receives FDA Clearance for its AI Product Intended to Detect Signs of Pulmonary Hypertension From Standard ECGs
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM) today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Tempus ECG-PH (pulmonary hypertension), an AI-enabled software device that analyzes standard 12-lead electrocardiograms (ECGs) for signs associated with pulmonary hypertension. Tempus ECG-PH is the third FDA-cleared device in Tempus’ growing cardiovascular portfolio, expanding the company’s suite of next-generation AI products aimed at ide...
-
West Marine Successfully Completes Financial Restructuring
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--West Marine, Inc. (together with its subsidiaries and affiliates, “West Marine” or the “Company”), the nation's leading omnichannel provider of marine aftermarket products, announced that it has successfully emerged from Chapter 11, marking the completion of its comprehensive financial restructuring and positioning West Marine to better serve its customers across every channel. The Company exits Chapter 11 with increased flexibility to continue investing...
-
H.B. Fuller Board Unanimously Rejects Unsolicited Proposal from Ancora
ST. PAUL, Minn.--(BUSINESS WIRE)--H.B. Fuller Company (“H.B. Fuller” or “the Company”) (NYSE: FUL), the world’s largest pureplay adhesives company, today announced that, following a thorough review supported by independent financial and legal advisors, its Board of Directors has unanimously rejected Ancora’s unsolicited, non-binding proposal to acquire its Building Adhesives Solutions (“BAS”) business. The full text of H.B. Fuller’s Board's response letter is set forth below. Dear Fredrick and...